|
ZNF426 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.32680000506514E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.85729999555318E-08 |
| Normal-vs-Stage2 |
8.05670000000314E-05 |
| Normal-vs-Stage3 |
1.813530E-04 |
| Normal-vs-Stage4 |
6.08029999999982E-05 |
| Stage1-vs-Stage2 |
7.566000E-01 |
| Stage1-vs-Stage3 |
7.062600E-01 |
| Stage1-vs-Stage4 |
2.883800E-01 |
| Stage2-vs-Stage3 |
9.803600E-01 |
| Stage2-vs-Stage4 |
2.489000E-01 |
| Stage3-vs-Stage4 |
2.927400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.18269999641541E-08 |
| Normal-vs-AfricanAmerican |
2.29290000000049E-05 |
| Normal-vs-Asian |
1.400250E-04 |
| Caucasian-vs-AfricanAmerican |
5.251400E-01 |
| Caucasian-vs-Asian |
2.816200E-01 |
| AfricanAmerican-vs-Asian |
2.113600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21970228256419E-11 |
| Normal-vs-Female |
2.859900E-03 |
| Male-vs-Female |
1.482160E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.040520E-04 |
| Normal-vs-Extreme_Weight |
1.1770995289595E-10 |
| Normal-vs-Obese |
3.57330000000378E-06 |
| Normal-vs-Extreme_Obese |
7.98430000000794E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.220180E-01 |
| Normal_Weight-vs-Obese |
9.837600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.795600E-01 |
| Extreme_Weight-vs-Obese |
3.368300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.701600E-01 |
| Obese-vs-Extreme_Obese |
3.597200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.796000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.79489999999161E-06 |
| Normal-vs-Age(61-80Yrs) |
2.97919999781016E-09 |
| Normal-vs-Age(81-100Yrs) |
1.29459999997916E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.392600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.547200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.493800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.968200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.758200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.918000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.34999789125345E-11 |
| Normal-VS-Type2 PRCC |
4.45950000038664E-07 |
| Normal-VS-KIRP CIMP |
1.813930E-04 |
| Normal-VS-Unclassified PRCC |
3.688300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.249000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.389600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.588000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.577800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.312400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.603800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.55210330435807E-11 |
| Normal-vs-N1 |
2.257500E-03 |
| Normal-vs-N2 |
1.238980E-04 |
| N0-vs-N1 |
1.973650E-01 |
| N0-vs-N2 |
1.679450E-01 |
| N1-vs-N2 |
3.758500E-03 |
|
|
